Cargando…
A clinicopathological study of selected cognitive impairment cases in Lothian, Scotland: enhanced CJD surveillance in the 65 + population group
BACKGROUND: Variant Creutzfeldt-Jakob Disease (vCJD) is primarily associated with dietary exposure to bovine-spongiform-encephalopathy. Cases may be missed in the elderly population where dementia is common with less frequent referral to specialist neurological services. This study’s twin aims were...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298168/ https://www.ncbi.nlm.nih.gov/pubmed/35858858 http://dx.doi.org/10.1186/s12877-022-03280-4 |
_version_ | 1784750642782273536 |
---|---|
author | Kanguru, Lovney Logan, Gemma Waddel, Briony Smith, Colin Molesworth, Anna Knight, Richard |
author_facet | Kanguru, Lovney Logan, Gemma Waddel, Briony Smith, Colin Molesworth, Anna Knight, Richard |
author_sort | Kanguru, Lovney |
collection | PubMed |
description | BACKGROUND: Variant Creutzfeldt-Jakob Disease (vCJD) is primarily associated with dietary exposure to bovine-spongiform-encephalopathy. Cases may be missed in the elderly population where dementia is common with less frequent referral to specialist neurological services. This study’s twin aims were to determine the feasibility of a method to detect possible missed cases in the elderly population and to identify any such cases. METHODS: A multi-site study was set-up in Lothian in 2016, to determine the feasibility of enhanced CJD-surveillance in the 65 + population-group, and undertake a clinicopathological investigation of patients with features of ‘atypical’ dementia. RESULTS: Thirty patients are included; 63% male, 37% female. They were referred because of at least one neurological feature regarded as ‘atypical’ (for the common dementing illnesses): cerebellar ataxia, rapid progression, or somato-sensory features. Mean-age at symptom-onset (66 years, range 53–82 years), the time between onset-of-symptoms and referral to the study (7 years, range 1–13 years), and duration-of-illness from onset-of-symptoms until death or the censor-date (9.5 years, range 1.1–17.4 years) were determined. By the censor-date, 9 cases were alive and 21 had died. Neuropathological investigations were performed on 10 cases, confirming: Alzheimer’s disease only (2 cases), mixed Alzheimer’s disease with Lewy bodies (2 cases), mixed Alzheimer’s disease with amyloid angiopathy (1 case), moderate non-amyloid small vessel angiopathy (1 case), a non-specific neurodegenerative disorder (1 case), Parkinson's disease with Lewy body dementia (1 case), and Lewy body dementia (2 cases). No prion disease cases of any type were detected. CONCLUSION: The surveillance approach used was well received by the local clinicians and patients, though there were challenges in recruiting sufficient cases; far fewer than expected were identified, referred, and recruited. Further research is required to determine how such difficulties might be overcome. No missed cases of vCJD were found. However, there remains uncertainty whether this is because missed cases are very uncommon or because the study had insufficient power to detect them. |
format | Online Article Text |
id | pubmed-9298168 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-92981682022-07-21 A clinicopathological study of selected cognitive impairment cases in Lothian, Scotland: enhanced CJD surveillance in the 65 + population group Kanguru, Lovney Logan, Gemma Waddel, Briony Smith, Colin Molesworth, Anna Knight, Richard BMC Geriatr Research BACKGROUND: Variant Creutzfeldt-Jakob Disease (vCJD) is primarily associated with dietary exposure to bovine-spongiform-encephalopathy. Cases may be missed in the elderly population where dementia is common with less frequent referral to specialist neurological services. This study’s twin aims were to determine the feasibility of a method to detect possible missed cases in the elderly population and to identify any such cases. METHODS: A multi-site study was set-up in Lothian in 2016, to determine the feasibility of enhanced CJD-surveillance in the 65 + population-group, and undertake a clinicopathological investigation of patients with features of ‘atypical’ dementia. RESULTS: Thirty patients are included; 63% male, 37% female. They were referred because of at least one neurological feature regarded as ‘atypical’ (for the common dementing illnesses): cerebellar ataxia, rapid progression, or somato-sensory features. Mean-age at symptom-onset (66 years, range 53–82 years), the time between onset-of-symptoms and referral to the study (7 years, range 1–13 years), and duration-of-illness from onset-of-symptoms until death or the censor-date (9.5 years, range 1.1–17.4 years) were determined. By the censor-date, 9 cases were alive and 21 had died. Neuropathological investigations were performed on 10 cases, confirming: Alzheimer’s disease only (2 cases), mixed Alzheimer’s disease with Lewy bodies (2 cases), mixed Alzheimer’s disease with amyloid angiopathy (1 case), moderate non-amyloid small vessel angiopathy (1 case), a non-specific neurodegenerative disorder (1 case), Parkinson's disease with Lewy body dementia (1 case), and Lewy body dementia (2 cases). No prion disease cases of any type were detected. CONCLUSION: The surveillance approach used was well received by the local clinicians and patients, though there were challenges in recruiting sufficient cases; far fewer than expected were identified, referred, and recruited. Further research is required to determine how such difficulties might be overcome. No missed cases of vCJD were found. However, there remains uncertainty whether this is because missed cases are very uncommon or because the study had insufficient power to detect them. BioMed Central 2022-07-20 /pmc/articles/PMC9298168/ /pubmed/35858858 http://dx.doi.org/10.1186/s12877-022-03280-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Kanguru, Lovney Logan, Gemma Waddel, Briony Smith, Colin Molesworth, Anna Knight, Richard A clinicopathological study of selected cognitive impairment cases in Lothian, Scotland: enhanced CJD surveillance in the 65 + population group |
title | A clinicopathological study of selected cognitive impairment cases in Lothian, Scotland: enhanced CJD surveillance in the 65 + population group |
title_full | A clinicopathological study of selected cognitive impairment cases in Lothian, Scotland: enhanced CJD surveillance in the 65 + population group |
title_fullStr | A clinicopathological study of selected cognitive impairment cases in Lothian, Scotland: enhanced CJD surveillance in the 65 + population group |
title_full_unstemmed | A clinicopathological study of selected cognitive impairment cases in Lothian, Scotland: enhanced CJD surveillance in the 65 + population group |
title_short | A clinicopathological study of selected cognitive impairment cases in Lothian, Scotland: enhanced CJD surveillance in the 65 + population group |
title_sort | clinicopathological study of selected cognitive impairment cases in lothian, scotland: enhanced cjd surveillance in the 65 + population group |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298168/ https://www.ncbi.nlm.nih.gov/pubmed/35858858 http://dx.doi.org/10.1186/s12877-022-03280-4 |
work_keys_str_mv | AT kangurulovney aclinicopathologicalstudyofselectedcognitiveimpairmentcasesinlothianscotlandenhancedcjdsurveillanceinthe65populationgroup AT logangemma aclinicopathologicalstudyofselectedcognitiveimpairmentcasesinlothianscotlandenhancedcjdsurveillanceinthe65populationgroup AT waddelbriony aclinicopathologicalstudyofselectedcognitiveimpairmentcasesinlothianscotlandenhancedcjdsurveillanceinthe65populationgroup AT smithcolin aclinicopathologicalstudyofselectedcognitiveimpairmentcasesinlothianscotlandenhancedcjdsurveillanceinthe65populationgroup AT molesworthanna aclinicopathologicalstudyofselectedcognitiveimpairmentcasesinlothianscotlandenhancedcjdsurveillanceinthe65populationgroup AT knightrichard aclinicopathologicalstudyofselectedcognitiveimpairmentcasesinlothianscotlandenhancedcjdsurveillanceinthe65populationgroup AT kangurulovney clinicopathologicalstudyofselectedcognitiveimpairmentcasesinlothianscotlandenhancedcjdsurveillanceinthe65populationgroup AT logangemma clinicopathologicalstudyofselectedcognitiveimpairmentcasesinlothianscotlandenhancedcjdsurveillanceinthe65populationgroup AT waddelbriony clinicopathologicalstudyofselectedcognitiveimpairmentcasesinlothianscotlandenhancedcjdsurveillanceinthe65populationgroup AT smithcolin clinicopathologicalstudyofselectedcognitiveimpairmentcasesinlothianscotlandenhancedcjdsurveillanceinthe65populationgroup AT molesworthanna clinicopathologicalstudyofselectedcognitiveimpairmentcasesinlothianscotlandenhancedcjdsurveillanceinthe65populationgroup AT knightrichard clinicopathologicalstudyofselectedcognitiveimpairmentcasesinlothianscotlandenhancedcjdsurveillanceinthe65populationgroup |